Saturday, April 13, 2013

New device could cut costs on household products, pharmaceuticals

New device could cut costs on household products, pharmaceuticals [ Back to EurekAlert! ] Public release date: 12-Apr-2013
[ | E-mail | Share Share ]

Contact: Michelle Ma
mcma@uw.edu
206-543-2580
University of Washington

Sometimes cost saving comes in nanoscale packages.

A new procedure that thickens and thins fluid at the micron level could save consumers and manufacturers money, particularly for soap products that depend on certain molecules to effectively deal with grease and dirt. Researchers at the University of Washington published their findings online April 9 in the Proceedings of the National Academy of Sciences.

Read the back of most shampoos and dishwashing detergents and you'll find the word "surfactant" in the list of active ingredients. Surfactant molecules are tiny, yet they are the reason dish soap can attack an oily spot and shampoo can rid the scalp of grease.

Surfactant molecules are made up of two main parts, a head and a tail. Heads are attracted to water, while the tails are oil-soluble. This unique structure helps them break down and penetrate grease and oil while immersed in water. It also makes the soaps, shampoos and detergents thicker, or more viscous.

Soap manufacturers add organic and synthetic surfactants and often a slew of other ingredients to their products to achieve a desired thickness and to help remove grease and dirt. These extra ingredients add volume to the soap products, which then cost more to manufacture, package and ship, ultimately shifting more costs to consumers, said Amy Shen, a UW associate professor of mechanical engineering and lead author of the paper.

The research team's design could create the same thickening results without having to add extra ingredients.

"Our flow procedure can potentially help companies and consumers save a lot of money," Shen said. "This way, companies don't have to add too many surfactants to their products."

Researchers found that when they manipulated the flow of a liquid through microscopic channels, the resulting substance became thicker. Now, scientists add a lot of salt, or alter the temperature and level of acidity to induce this change, but these methods can be expensive and more toxic, Shen said.

The team built a palm-sized tool called a microfluidics device that lets researchers pump water mixed with a little detergent and salt through a series of vertical posts. The distance between posts is about one-tenth the size of a single human hair. That micron-sized gap squeezes the liquid as it flows, causing it to quickly deform. The end result is a gel-like substance that's more viscous and elastic.

When researchers looked at high-resolution images of the end product, they saw a series of wormlike rods attaching and intermingling with each other, creating an entangled web. This structure stayed intact after the procedure was complete, which suggests this process can create a permanent, scaffold-like network that could prove useful for biological applications, Shen said. She is collaborating with other UW researchers to try to create stable structures that could house enzymes and other biomarkers for detecting certain diseases.

Shen and her team also discovered that when they pumped a thicker, more elastic fluid through the device, the opposite effect happened the gel became thinner and more porous. This could be useful in biomedical applications, Shen said, though it hasn't yet been tested. In theory, a semi-solid gel could be injected into veins, then transform into a thinner liquid, delivering drugs throughout the body.

Researchers hope one eventual outcome will be a scaled-up industrial design of their microfluidics device that could help manufacturers churn out soap products that aren't filled with an excess of added materials. Shen has presented her initial findings at Procter & Gamble Co.

"What we can provide are all of the important parameters for operating conditions so companies can have an industrial design to achieve their goals," Shen said.

###

Research collaborators are Joshua Cardiel and Ya Zhao, UW doctoral students in mechanical engineering; Alice Dohnalkova, senior research scientist at Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory in Richland, Wash.; and Neville Dubash and Perry Cheung, former post-doctoral researchers in mechanical engineering.

The research was funded by the National Science Foundation.

For more information, contact Shen at amyshen@uw.edu or 206-708-3411.

Read the paper: http://www.pnas.org/content/early/2013/04/03/1215353110.abstract?sid=5d4db223-06e2-45a1-89ce-e50205986032

Shen's faculty webpage: http://www.me.washington.edu/research/faculty/amyshen/index.php

Shen's lab homepage: http://depts.washington.edu/softmatt/


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


New device could cut costs on household products, pharmaceuticals [ Back to EurekAlert! ] Public release date: 12-Apr-2013
[ | E-mail | Share Share ]

Contact: Michelle Ma
mcma@uw.edu
206-543-2580
University of Washington

Sometimes cost saving comes in nanoscale packages.

A new procedure that thickens and thins fluid at the micron level could save consumers and manufacturers money, particularly for soap products that depend on certain molecules to effectively deal with grease and dirt. Researchers at the University of Washington published their findings online April 9 in the Proceedings of the National Academy of Sciences.

Read the back of most shampoos and dishwashing detergents and you'll find the word "surfactant" in the list of active ingredients. Surfactant molecules are tiny, yet they are the reason dish soap can attack an oily spot and shampoo can rid the scalp of grease.

Surfactant molecules are made up of two main parts, a head and a tail. Heads are attracted to water, while the tails are oil-soluble. This unique structure helps them break down and penetrate grease and oil while immersed in water. It also makes the soaps, shampoos and detergents thicker, or more viscous.

Soap manufacturers add organic and synthetic surfactants and often a slew of other ingredients to their products to achieve a desired thickness and to help remove grease and dirt. These extra ingredients add volume to the soap products, which then cost more to manufacture, package and ship, ultimately shifting more costs to consumers, said Amy Shen, a UW associate professor of mechanical engineering and lead author of the paper.

The research team's design could create the same thickening results without having to add extra ingredients.

"Our flow procedure can potentially help companies and consumers save a lot of money," Shen said. "This way, companies don't have to add too many surfactants to their products."

Researchers found that when they manipulated the flow of a liquid through microscopic channels, the resulting substance became thicker. Now, scientists add a lot of salt, or alter the temperature and level of acidity to induce this change, but these methods can be expensive and more toxic, Shen said.

The team built a palm-sized tool called a microfluidics device that lets researchers pump water mixed with a little detergent and salt through a series of vertical posts. The distance between posts is about one-tenth the size of a single human hair. That micron-sized gap squeezes the liquid as it flows, causing it to quickly deform. The end result is a gel-like substance that's more viscous and elastic.

When researchers looked at high-resolution images of the end product, they saw a series of wormlike rods attaching and intermingling with each other, creating an entangled web. This structure stayed intact after the procedure was complete, which suggests this process can create a permanent, scaffold-like network that could prove useful for biological applications, Shen said. She is collaborating with other UW researchers to try to create stable structures that could house enzymes and other biomarkers for detecting certain diseases.

Shen and her team also discovered that when they pumped a thicker, more elastic fluid through the device, the opposite effect happened the gel became thinner and more porous. This could be useful in biomedical applications, Shen said, though it hasn't yet been tested. In theory, a semi-solid gel could be injected into veins, then transform into a thinner liquid, delivering drugs throughout the body.

Researchers hope one eventual outcome will be a scaled-up industrial design of their microfluidics device that could help manufacturers churn out soap products that aren't filled with an excess of added materials. Shen has presented her initial findings at Procter & Gamble Co.

"What we can provide are all of the important parameters for operating conditions so companies can have an industrial design to achieve their goals," Shen said.

###

Research collaborators are Joshua Cardiel and Ya Zhao, UW doctoral students in mechanical engineering; Alice Dohnalkova, senior research scientist at Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory in Richland, Wash.; and Neville Dubash and Perry Cheung, former post-doctoral researchers in mechanical engineering.

The research was funded by the National Science Foundation.

For more information, contact Shen at amyshen@uw.edu or 206-708-3411.

Read the paper: http://www.pnas.org/content/early/2013/04/03/1215353110.abstract?sid=5d4db223-06e2-45a1-89ce-e50205986032

Shen's faculty webpage: http://www.me.washington.edu/research/faculty/amyshen/index.php

Shen's lab homepage: http://depts.washington.edu/softmatt/


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2013-04/uow-ndc041213.php

juan pablo montoya free pancakes at ihop martina navratilova high school shooting ohio school shooting sean young arrested matt kenseth

Friday, April 12, 2013

Venezuela election to test Chavez's socialist legacy

By Daniel Wallis

CARACAS (Reuters) - The late Hugo Chavez's self-declared socialist revolution will be put to the test at a presidential election on Sunday that pits his chosen successor against a younger rival promising change in the nation he polarized.

Most opinion polls give his protege, acting President Nicolas Maduro, a strong lead thanks to Chavez's endorsement and the surge of grief and sympathy over his death from cancer last month.

Maduro, a burly 50-year-old former bus driver, is promising to be faithful to Chavez's socialist policies and he has copied his former boss' fierce rhetoric throughout the campaign.

"Do you want one of the rancid bourgeois to win?" Maduro shouted at one of his closing rallies. "Or do you want a worker, a son of Chavez, a patriot and a revolutionary? You decide!"

Waving posters of his late boss, the crowd sang back the campaign slogan: "Chavez, I swear to you, I'll vote for Maduro!"

Opposition candidate Henrique Capriles, the 40-year-old governor of Miranda state, says Venezuelans need a change from the divisive politics of Chavez's 14-year rule, and he is hoping a late surge will turn things in his favor.

At stake is control of the world's biggest crude oil reserves, economic aid to a host of left-leaning governments around Latin America, and the legacy of "Chavismo" socialism.

At each of his campaign events, Maduro has played a video of Chavez giving him his blessing in an emotional last speech to the OPEC nation of 29 million people before he succumbed to cancer on March 5.

If Maduro wins, he will face big challenges from day one as he seeks to control the disparate ruling coalition without his predecessor's dominant personality or the robust state finances that helped the ailing Chavez win re-election just last October.

Capriles would face an even tougher landscape if he wins as he would have to try to win over Chavez's millions of ferociously loyal supporters, including suspicious employees at state-run companies that have long been tied to Chavez's movement.

At every rally, Capriles has rejected Maduro's claims that he plans to cancel the oil-funded social welfare projects, or slum "missions", that were a high-profile cornerstone of the late president's popularity with the poor.

Capriles has drawn blood with scathing attacks on Maduro and others whom he denounces as "skin-deep revolutionaries." He accuses them of betraying Chavez's legacy by filling their pockets while paying only lip service to his ideology.

Maduro, meanwhile, paints his rival as a pampered rich kid who represents a wealthy and venal Venezuelan elite - and their "imperial" financial backers in Washington.

MADURO STRESSES TIES TO CHAVEZ

A descendant of European Jews on his mother's side, Capriles does come from a wealthy family, but has sought to project a man-of-the-people image riding into slums on his motorbike and nearly always wearing a baseball cap.

Maduro, a former member of a rock band and a union activist, rose to be Chavez's foreign minister and vice president, but has been playing up his modest roots at rallies, frequently calling onto stage fellow workers whom he recognizes.

During a bitter, lightning campaign punctuated by highly personalized attacks from both candidates, Maduro has stressed his close ties to Chavez at every turn. He even said he was visited by the late leader's spirit in the form a little bird.

In another surreal turn, Maduro also warned anyone thinking of voting for his rival that they would bring down a centuries-old curse upon themselves, playing on the fertile mix of animist and Christian beliefs in Venezuela's plains and jungles.

In a nation where Chavez's confrontational rhetoric helped fuel deep mistrust between his supporters and the opposition, both political camps have repeatedly accused the other of dirty tricks and fomenting violent plans.

Loyal "Chavistas" often accuse the opposition of plotting a re-run of a brief coup against Chavez a decade ago, while the Capriles camp says the government is shamelessly using state resources to try to ensure Maduro's triumph.

Maduro has accused the opposition of planning to use mercenaries to kill him and sabotage the electricity grid, and also accused the U.S. government of plotting to kill Capriles and then blame it on his administration to sow chaos.

Capriles says those kind of shrill claims are an echo of the worst of Chavez's rule, and only aim to spread distrust and fear. Chavez himself often unveiled supposed assassination plans targeting him, which critics dismissed as cynical efforts to keep voters on a war footing and distract them from daily worries such as violent crime, inflation and corruption.

Capriles also sees the hand of Cuba's Castro brothers - close allies of the late Chavez - in Maduro's campaign.

"You can win the elections in Havana. I'm going to win them here in Venezuela," Capriles said in one of his final speeches.

"I'm not the opposition, I'm the solution! ... I ask the late president's supporters to vote for me. Nicolas is not Chavez. Capriles is the guarantee that this country advances."

He is offering a Brazil-style model that blends pro-business policies with strong spending on social welfare projects, and he says Maduro's tenure as acting leader has only added to people's problems with a devaluation and new currency controls.

Capriles says that if he wins he will stop "gifting" Venezuela's oil wealth to other nations, and will cool ties with distant Chavez-era allies such as Syria, Belarus and Iran.

The U.S. government will be watching the vote closely in the hope of better relations after years of tensions with Chavez.

Despite being often out of sight during his illness, Chavez easily defeated Capriles in last October's vote. It was his fourth presidential election victory, demonstrating the enduring support for his policies two decades after he burst onto Venezuela's political scene with a failed coup.

Many supporters say they will stay true to the dying wish of their "commander" and vote for Maduro, whatever they may feel about how he stacks up as successor to the towering Chavez.

"It's a question of loyalty. It doesn't matter who the candidate is," said Luis Vegas, a 23-year-old motorcycle courier from the huge Petare slum in Caracas. "On Sunday, we will show our support for Chavez and continue defending his revolution."

(Editing by Andrew Cawthorne, Kieran Murray and Lisa Shumaker)

Source: http://news.yahoo.com/venezuelas-opposition-denies-scrap-chavez-welfare-aid-000208339.html

masters leaderboard Chris Webber linda perry Champions League luke bryan WrestleMania 29 Lilly Pulitzer

Wash. jury rejects claim of actress who sued IMDb

SEATTLE (AP) ? A federal jury in Seattle on Thursday rejected a claim brought by a little-known actress who first lied about how old she was on the popular Internet Movie Database, then sued the company when it published her true age.

Huong Hoang goes by the stage name Junie Hoang and has appeared in such films as "Gingerdead Man 3: Saturday Night Cleaver" and "Hoodrats 2: Hoodrat Warriors."

Her lawsuit generated a lot of media attention when she filed it ? anonymously, at first ? in 2011. She said she intended for her case to highlight online privacy as well as age discrimination in Hollywood, and she initially sought $1 million in damages.

"My hope was that it would make a change in the database," Hoang told The Associated Press after the verdict. "I knew it was a problem not just for me but for anyone else who had their age on their profile."

The 41-year-old claimed offers for roles dried up after the popular online movie database mined her account information to learn her true age, then posted it on her profile in 2008. She sued for breach of contract, and the case went to trial this week. The judge dismissed IMDb's parent company, Amazon.com, as a defendant before the trial.

IMDb argued that it has a First Amendment right to publish accurate information. It also said Hoang couldn't prove she lost any money or roles because of it, and even if she could, she couldn't prove it was IMDb's fault.

"Hoang did not present any testimony, documents, or other evidence supporting her damages allegations of lost income and profits," the company's lawyers wrote in a court filing at the end of the trial.

IMDb.com is an searchable database that includes more than 2 million pages for movies, television and entertainment programs, as well as 4 million cast and crew members.

Hoang signed up for a subscription service with the website called IMDb Pro. The service is designed for entertainment industry professionals. It provides contact information and other details for the actors, actresses, directors and others listed.

She said she initially listed a false birth year ? 1978, instead of 1971 ? because she usually plays characters younger than she is.

But eventually, she moved from her hometown of Houston, Texas, to the more competitive entertainment market of Los Angeles, and as what would have been her fake 30th birthday approached, she decided she didn't want any age listed on her profile.

IMDb refused to remove the age listed unless she could provide evidence that it was incorrect. She asked the company to check its records to see if it had any information that would substantiate that age.

The company did so ? using her account information to find her real name, and then using her real name to conduct a public records search and discover her true age. IMDb posted her real age on her profile, over her objections.

She claimed that the company breached its contract with her by misusing the account information she provided in violation of its privacy policy. The company disagreed, noting that the privacy policy stated that it maintained its customers' information "for such purposes as responding to your requests."

Hoang said she plans to keep acting.

She played Sandy in "Gingerdead Man 3," a sequel to a 2005 Gary Busey movie in which "an evil yet adorable gingerbread man comes to life with the soul of a convicted killer," according to a description on IMDb.

Other credits include a part as a triage nurse in the television series "I Didn't Know I Was Pregnant," and as the part of Janet in "My Big Phat Hip Hop Family."

___

Johnson can be reached at https://twitter.com/GeneAPseattle

Source: http://news.yahoo.com/wash-jury-rejects-claim-actress-sued-imdb-235021245.html

Michael Clark Duncan michael jackson courtney stodden Ncaa Football Scores Plaquemines Parish michigan football michigan football

Bloomberg scolds media for focusing on Anthony Weiner?s past

April 11 (Reuters) - FC Basel 2 Tottenham Hotspur 2 - EuropaLeague quarter-final second leg result after extra time FC Basel win 4-1 on penalties, aggregate score 4-4 (Halftime 1-1, 90 minutes 2-2) At St Jakob Park, Basel Scorers: FC Basel - Mohamed Salah 27, Aleksander Dragovic 49 Tottenham Hotspur - Clint Dempsey 23, 82 Red card: Jan Vertonghen (Tottenham Hotspur 90) Halftime: 1-1; Attendance: 36,500 FC Basel: 1-Yann Sommer; 4-Philipp Degen, 16-Fabian Schaer,6-Aleksander Dragovic, 3-Park Joo Ho; 33-Mohamed Elneny,20-Fabian Frei, 8-Serey Die (21-Marcelo Diaz 59); 22-MohamedSalah (11-Alexander ...

Source: http://news.yahoo.com/blogs/ticket/bloomberg-scolds-media-focusing-anthony-weiner-past-201007786--politics.html

the replacements how to hard boil eggs new nfl uniforms derbyshire the matrix oceans 11 ferris state hockey

Buzz Launcher Is Packed with Home Screen Tweaks, User-Built Themes, and More

Buzz Launcher Is Packed with Home Screen Tweaks, User-Built Themes, and MoreBuzz Launcher Is Packed with Home Screen Tweaks, User-Built Themes, and More Android (4.0+): If you like tweaking and customizing your Android phone's look and feel, or wish you could but don't know how, Buzz Launcher is the launcher you've been waiting for. It's in beta, but it already packs tons of layout options, widgets, downloadable themes, and gesture controls.

Buzz Launcher is free, and while it's still in beta, is still boasts thousands of downloadable themes from other users. When you install Buzz Launcher, you join a community, all sharing and making their home screen configurations available to one another download and install. If you find someone who makes particularly smart use of gestures, or someone else who's customized the lock screen in a really nice way, you can add their setup to your phone immediately.

Even if you don't want to use anyone else's pre-made home screen, you can design your own. Buzz Launcher lets you set multiple wallpapers for different home screens, edit individual app icons and their sizes, customize the icon grid so you can fit more apps on one screen, add a quick-launch sidebar, add widgets to the lock screen, and more. Buzz Launcher even has a widget editor that lets you customize them before placing them. Hit the link below to grab the app from Google Play, or read more about its features.

Buzz Launcher Beta (Free) | Google Play via Addictive Tips

Source: http://feeds.gawker.com/~r/lifehacker/full/~3/Jg3NjaLgdiQ/buzz-launcher-is-packed-with-customization-tools-community+built-themes-and-more

rampart nick collins dave matthews ambien wwdc madden 13 cover dalai lama

Genes reveal which patients will benefit from scleroderma drug ...

? Drug Abuse ? ? Immunology ? Apr 10, 2013

Systemic sclerosis, also known as scleroderma, is a rare autoimmune connective tissue disorder that?s difficult to treat. However, thanks to new research at Northwestern University Feinberg School of Medicine and Dartmouth?s Geisel School of Medicine, doctors may be able to treat some patients more effectively.

Characterized by thickening of the skin, scleroderma can also cause significant complications in the joints and internal organs - particularly the esophagus, lower gastrointestinal tract, lungs, heart and kidneys. There is no cure - and the one drug commonly used to treat the disease, mycophenolate mofetile (MMF) does not work for all patients. In the absence of a biomarker to inform therapeutic medical decisions, patients are exposed to ineffective and potentially toxic medications.

In the first study of its kind in scleroderma, Monique Hinchcliff, M.D., assistant professor of medicine at the Feinberg School, associate director of the Northwestern Scleroderma Program, and a physician at Northwestern Memorial Hospital, and Michael Whitfield, associate professor of genetics at the Geisel School of Medicine, together have shown that gene expression signatures can accurately identify patients who will positively respond to a particular therapy.

The paper was recently published electronically in the Journal of Investigative Dermatology.

?There is the potential for adverse reactions including death with scleroderma therapies, and delay in initiating appropriate therapy can be harmful,? Hinchcliff said. ?Selecting effective treatment for each patient is the major issue facing physicians treating scleroderma patients.?

Whitfield?s and Hinchcliff?s findings revealed that patients whose conditions improve with MMF therapy all share a particular gene expression pattern in skin.

During the clinical trial, patients who improved during MMF therapy were classified in the inflammatory gene expression subset, while patients who did not improve were classified in the normal-like or fibroproliferative gene expression subsets. This fits the initial hypothesis since MMF impairs lymphocyte proliferation.

Systemic sclerosis or systemic scleroderma is an autoimmune or connective tissue disease. It is characterized by thickening of the skin caused by accumulation of collagen, and by injuries to the smallest arteries. There are two overlapping forms. Limited cutaneous scleroderma is limited to the skin on the face, hands and feet. Diffuse cutaneous scleroderma covers more of the skin, and is at risk of progressing to the visceral organs, including the kidneys, heart, lungs and gastrointestinal tract are affected.

Survival is determined by the severity of visceral disease. Prognosis is difficult to predict until the disease differentiates into recognizable subsets. Patients with limited cutaneous scleroderma have a good prognosis, with 10-year survival of 75%, although

Annual incidence is 19 per million, and prevalence is 19-75 per 100,000, with a female:male ratio of 3:1, and 8:1 in mid to late childbearing years. Incidence is twice as high among African Americans, and the Choctow Native Americans in Oklahoma have the highest prevalence in the world (469/100,000). There is some hereditary association, some suggestion of immune reaction (molecular mimicry) to a virus, and some cases caused by toxins.[

An MMF response gene expression signature was also identified?the signature was composed of genes whose expression changed significantly during MMF treatment in patients that improved, but was absent in patients that did not improve.

The results of these experiments suggest that analysis of gene expression in skin may allow targeted treatment in patients with scleroderma.

While this is a small pilot study, it represents an important step forward in approaching complex rare diseases, such as scleroderma, where existing therapies show little or no efficacy, notes John Varga, M.D., the John and Nancy Hughes Professor at the Feinberg School and a physician at Northwestern Memorial, who also participated in the study.

If validated in a larger patient cohort now underway, the results will have significant impact on the development of effective treatment strategies for patients with systemic sclerosis.

###

The research paper is titled, ?Molecular Signatures in Skin Associated with Clinical Improvement During Mycophenolate Treatment in Systemic Sclerosis.?

This work was supported in part by grants K12 HD055884 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health, grants U01 AR055063 and R25CA134286 from the National Cancer Institute from the National Institutes of Health, grants P60 AR48098 and P50AR060780 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health and by the Arthritis Foundation, the Scleroderma Foundation and the Scleroderma Research Foundation.

###

Marla Paul
312-503-8928
Northwestern University

Provided by ArmMed Media




?Comments [ + Post Your Own ]?

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]


Get free support - Headache Causes, Symptoms, Diagnosis, and Treatment on HeadacheCare.net

Source: http://www.health.am/ab/more/patients-will-benefit-from-scleroderma-drug/

megamillions winners university of louisville louisville ky lotto winners mega ball winning numbers baltimore county current tv

Wednesday, March 13, 2013

Poultry checks strengthened at scandal-hit Liuhe: executive

By Lucy Hornby

BEIJING (Reuters) - Chinese poultry producer Liuhe Group Co is back to normal operations but with strengthened protocols, its controlling shareholder said, after being named for supplying chicken with excessive antibiotics to KFC.

In December, state television reported that poultry suppliers to fast-food chain KFC had fed chickens drugs and hormones to accelerate growth. Chinese food safety authorities also said they had found excessive amounts of antibiotics in samples tested from 2010 and 2011.

Yum Brands Inc, which owns KFC, has blamed the food safety scare for cutting same-store sales by 25 percent in the first two months of the year. It releases its February sales figures later on Monday.

"This has been a very big lesson for us that we need to pay attention to and increase food safety efforts," Liu Yonghao, founder of China's largest private agribusiness New Hope Group, told reporters on Monday. New Hope, China's top feed producer, owns Liuhe, one of China's largest chicken producers.

Liu said the excessive antibiotics were tracked to independent chicken breeders who supply Liuhe, not to poultry raised by Liuhe itself.

"Some breeders used too much antibiotics or medicines. These non-standard materials got into the supply chain, and the media reported on it," Liu said.

Yum said in January it had stopped sourcing from Liuhe in August and had stopped sourcing from a plant run by Yingtai Food Group before state television aired its report.

Liu said, "We are already back to normal. All the plants are back online. What should be closed or fixed has already been closed or fixed, and our company has released a pledge to improve food safety measures."

He defended the practice, common to industrial breeders in China and North America, of raising chicks to adulthood in just over 40 days rather than the natural span of three to six months through feeding and light control in sealed coops. The technique requires careful disease control in the crowded flock.

"After a month of tests the market has been opened again. Whether in Beijing, Sichuan or Shandong, across China the market has been opened again. Following inspections, our product meets the standards," Liu said.

In an interview with Reuters in 2006, Liuhe executives said they had carefully studied the American poultry industry's practices for accelerated chicken raising.

Most of Yum's nearly 5,300 restaurants in China are KFCs.

(editing by Jane Baird)

Source: http://news.yahoo.com/poultry-checks-strengthened-scandal-hit-liuhe-executive-133207789--finance.html

us open tennis Empire State Building shooting Republican National Convention Karlie Redd guild wars 2 adrian gonzalez Jerry Nelson